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ABSTRACT

Does Spaceflight Increase the Chance of Female Astronauts Developing Uterine Cancer?
by
Areej Mosa
One of the main questions put forth by NASA and the European Space Agency (ESA) is whether
or not an organism, especially mankind, can complete an entire life cycle in space. With this in
mind, it is essential to study the effect of spaceflight on reproductive tissues. Using simulated
microgravity techniques and whole-body radiation we sought to determine if females subjected
to a simulated spaceflight environment have increased incidences of uterine cancer. Uterine
tissue from mice subjected to simulated spaceflight was analyzed using immunohistochemical
staining and western blot analysis. Two pathways commonly activated in cancer were
investigated. Additionally, the uterine tissue was evaluated for gross morphological changes
using standard histological staining. The findings of this study indicate that none of the treatment
parameters used to simulate the spaceflight environment were found to induce uterine cancer.

2

DEDICATION
I dedicate this work to my family for the love, endless support, and encouragement
which helped me in completion of this thesis. My beloved and supportive husband, Issa, who is
always by my side when times I needed him most and my lovable baby, Karam, who served as
my inspiration to continue this undertaking. I thank them both for their continued unconditional
support and sacrifices.

3

ACKNOWLEDGEMENTS
First of all, I thank God for the wisdom He granted me, and for the strength, patience,
peace of mind which allowed me to finish this research.
I am really fortunate to have worked with Dr. Forsman as my mentor and advisor. Dr.
Forsman’s encouragement, support and guidance through the different phases of this project
made me a better researcher and made this thesis a reality. I thank him from the bottom of my
heart for everything he has done for me. I also want to extend my gratitude and thanks for my
committee members Dr. Alok Agrawal and Dr. James Stewart for being there and ready to help
whenever I needed it. I am really fortunate to have such a great committee to support me
through my research project.
I am highly indebted to the ETSU colleges of Biological and Biomedical Sciences for
their guidance and continuous supervision. I also thank them for providing necessary
information regarding the research. I would like to thank the faculty members of both the
Biological Sciences and Biomedical Sciences that have been tremendously supportive. Also,
special thanks go to the Biological Sciences Department and Graduate School for their generous
graduate assistantship and the research grant.
I would also like to recognize the generous support and provision of tissues from Dr.
Xiao Mao and Dr. Mike Pecaut of Loma Linda University. I also wish to thank Dr. Jonathan
Peterson and his graduate students Lyndsey Hagood and Ashley Degroat for their assistance in
conducting the Western Blot analysis.
My thanks and appreciation also go to my colleagues and people who have willingly
helped me out with their abilities. Could not thank you all enough for all your support.

4

TABLE OF CONTENTS
Page
ABSTRACT .................................................................................................................................... 2
DEDICATION ................................................................................................................................ 3
ACKNOWLEDGEMENTS ............................................................................................................ 4
LIST OF FIGURES ........................................................................................................................ 6
1. INTRODUCTION ...................................................................................................................... 7
Effect of Microgravity on the Cardiovascular System................................................................ 7
Musculoskeletal Changes in Microgravity ................................................................................. 9
The Effect of Microgravity on Immune system ........................................................................ 10
Genitourinary Problems During Spaceflight............................................................................. 11
Ground Based Models to Simulate Microgravity ..................................................................... 14
The Nature of Space Radiation ................................................................................................. 17
Sources and Effects of Radiation Exposure .............................................................................. 17
Effect of Radiation on Reproductive Health ............................................................................. 20
Endometrial Cancer................................................................................................................... 21
Genetic Alterations Involved in the Development of Uterine Cancer ...................................... 22
The PI3K/AKT Pathway ........................................................................................................... 23
The MAPK Pathway ................................................................................................................. 25
Objectives and Significance of this Study ................................................................................ 26
2. MATERIALS AND METHODS .............................................................................................. 28
Western Blot Procedure ............................................................................................................ 29
Histological Examination .......................................................................................................... 31
Statistical Analysis .................................................................................................................... 35
3. RESULTS ................................................................................................................................. 36
Gross Morphology of H&E Stained Uterine Tissues................................................................ 36
Immunohistochemical Evaluation............................................................................................. 37
Western Blot Analysis .............................................................................................................. 39
Expression of pAKT in 4 Months and 9 Months Post Treatment Uterine Tissues ............... 39
Expression of pMAPK in 4 Months and 9 Months Post Treatment Uterine Tissues ........... 41
4. DISCUSSION AND CONCLUSIONS .................................................................................... 43
REFERENCES.............................................................................................................................. 50
VITA ............................................................................................................................................. 59
5

LIST OF FIGURES
Figure

Page

1. Overview of The PI3K/AKT and MAPK pathways. ................................................................ 26
2. Longitudinal section of H&E stained uterine tissues from the animals sacrificed 9-months post
treatment (X100) . .................................................................................................................... 36
3. Longitudinal section of IHC stained uterine tissues from the animals sacrificed 4-months post
treatment (X100) . .................................................................................................................... 37
4. Longitudinal section of IHC stained uterine tissues from the animals sacrificed 9-months post
treatment (X100) . .................................................................................................................... 38
5. pAKT content in uterine samples from animals sacrificed 9 months post treatment .. ........... 39
6. pAKT content in uterine samples from the animals sacrificed 4 months post treatment .. ...... 40
7. pERK content in uterine samples from the animals sacrificed 9 months poste treatment .. ..... 41
8. pERK content in uterine samples from the animals sacrificed 4 months poste treatment . ...... 42

6

CHAPTER 1
INTRODUCTION
One of the main questions put forth by NASA and the European Space Agency (ESA) is
whether or not an organism, especially mankind, can complete an entire life cycle in space.
With this in mind, it is essential to study the effect of spaceflight on reproductive tissues as one
of the significant human organs. There are two factors involved with spaceflight that are
dramatically different from conditions on Earth. First, the spaceflight environment is one of
very low gravity (microgravity). Second, the spaceflight environment is one of relatively high
levels of radiation (galactic cosmic radiation) compared to that on Earth. Spaceflight has been
shown to have effects on many different tissues of the body (Williams et al. 2009). It is
unknown whether those effects are due to the microgravity of spaceflight, the elevated levels of
radiation, or a combination of the two.
The primary physiological responses of vertebrates to spaceﬂight microgravity include
ﬂuid shifts, cardiovascular problems, musculoskeletal unloading, disturbance of senses, and
immunity dysregulation (Pace 1977; Vernikos 1996).

Effect of Microgravity on the Cardiovascular System
Compromised cardiovascular functions have been reported in astronauts during
spaceflight. Orthostatic intolerance and reduced aerobic capacity seemed to be the most pressing
of cardiovascular issues faced by astronauts (Convertino 2009). Orthostatic intolerance is a
serious health problem that faces astronauts during re-entry into earth’s atmosphere and
immediately after landing. Orthostatic intolerance is characterized by inability to remain in
upright posture while maintaining adequate blood supply to the brain. One hypothesis that can
describe these changes is cephalad fluid shift (Charles and Lathers 1991). Normally on earth and
under the effect of 1g gravity, the hydrostatic pressure is higher in the lower body compartment
7

than the upper body. This is because the fluid in the upper part of the body exerts a pressure on
the fluid in the lower part of the body. Venous return is the volume of blood in systemic veins
that flow back to the heart. In a standing position, the return of venous blood to the upper part of
the body is challenged. This is because the blood flow has to overcome the effect of gravity. The
skeletal muscle pump helps force the blood toward heart. The peripheral veins in the legs have
one-way valves that do not allow backflow of blood away from the heart. These valves
counteract the gravitational pull and prevent backflow of blood when standing. Upon entering
the space environment, the skeletal muscle pump is still pushing the blood in a cephalad
direction, but there is no resistance to this blood flow because there is no gravitational force
pulling the blood back down. This fluid shift toward the head (cephalad) is called cephalad fluid
shift (Drake et al. 2015).
Microgravity initiates a fluid shift, due to absence of hydrostatic pressure gradients, with
blood and other fluids moving from lower limbs toward head and thorax. Facial swelling is a
common change in astronauts due to high blood supply in head region. During spaceflight, the
volume in lower limbs is reduced by 10% compared with preflight (Leach et al. 1991). Earth
based models which are used to study these changes showed that cephalad fluid shifts distend
baroreceptors of the central vasculature. This triggers the suppression of the renin-angiotensinaldosterone system (RAAS). Suppression of the RAAS leads to increased renal excretion of salt
and water, and a net reduction in plasma volume (Vernikos 1995). Changes in the vestibular
system, especially in processing inputs from otolith receptors, is another hypothesis to describe
orthostatic intolerance. Altered gravity produces significant changes in the vestibular system and
this leads to changes in sympathetic nervous system activity including blood pressure regulation
(Yates and Kerman 1998). Further investigation is required to explain the relation between
vestibular changes and orthostatic intolerance.
8

Musculoskeletal Changes in Microgravity
The effect of actual and simulated microgravity on the musculoskeletal system is well
documented. Absence of gravitational loading during spaceflight leads to muscle atrophy and
bone demineralization. Weightlessness was shown to lead to changes in muscle structure and
function. These changes appear mainly as a decline in muscle mass, volume, and strength (di
Prampero and Narici 2003). Muscle atrophy mainly occurs due to imbalance in protein synthesis
and degradation. In general, there is an increase in protein degradation and a decrease in protein
synthesis, and loss of neuromuscular control. These causes are attributed to loss of gravitational
loading. The most affected muscles are postural muscles, such as those found in the calf and
thigh, that maintain our bodies in an upright position in a gravitational environment (Clément
2011).
Bone demineralization is a well-known health consequence of long duration spaceflight
which was recognized even long before the first manned space mission. The loss of bone mass
during spaceflight could eventually weaken the bone and increase the risk of fracture and so
presents problems to astronauts upon return to a normal gravity environment. Studies of
astronauts who spent months on space station Mir and Skylab, and also ground based models
simulating microgravity, all showed that astronauts could lose 1-2% of bone mass. This loss
occurred predominantly in load bearing areas of legs and lumbar spine (Vico et al. 2000; Lang et
al. 2004; LeBlanc et al. 2007). Data from space ﬂight studies showed increased urinary and fecal
excretion of calcium and increased markers of bone resorption. Calcium concentration is
controlled mainly by parathyroid hormone (PTH) and calcitonin. PTH is responsible for bone
resorption and thus activated when the blood calcium concentration is low. Normally, serum
calcium and PTH are negatively correlated: when the level of calcium in the blood is low, the
concentration of PTH will be high in response. Reduced levels of parathyroid hormone and
9

vitamin D in astronauts are expected physiologic responses to increased blood calcium resulting
from microgravity-induced bone loss (Smith and Heer 2002). One possible explanation for this
bone loss is the reduced gene expression of systemic hormones and growth factors (such as
collagen Iα1, alkaline phosphatase, and osteocalcin) that are considered important for osteoblast
differentiation (Carmeliet et al. 1998). Other studies showed a several fold increase in genes
involved in osteoclast activity and maturation (Tamma et al. 2009). Impaired osteoblast function
and increased osteoclast activity could explain osteoporosis like symptoms associated with space
flight.

The Effect of Microgravity on Immune System
There is strong evidence associated with impaired immune system functions and space
flight. Immune dysregulation in astronauts was first observed in the 1960s and 1970s as
increased incidences of bacterial and viral infections were reported during or immediately after
space flight. Fifteen of 29 Apollo crew members developed bacterial or viral infections during
their missions or within the first week after their return (Hawkins and Zieglschmid 1975). Much
is known about the immune health of astronauts from post flight testing of crew members, but
little data are available about immunity during space flight. More in-flight investigation using
human subjects is needed. These alterations of immune function could be attributed to high
levels of physiological and physical stress during and immediately after space flight. Factors like
radiation, microgravity, and altered sleep cycle could all affect the astronaut’s immune system.
The few in flight studies that have been conducted have shown reactivation and increased
frequencies of Epstein bar virus, varicella zoster virus and cytomegalovirus (Mehta et al. 2000,
2003; Pierson et al. 2005). Reduced cell mediated immunity is also reported in in-flight studies
(Gmünder et al. 1994). Post flight studies have revealed depression of T cell function during long
duration flight, altered cytokine production, reduced function of natural killer cells and
10

granulocytes, and latent viral reactivation (Crucian et al. 2009). Altered cytokine production and
potential shifts to a T-helper 2 (Th2) pattern lead to immune imbalance and adverse health
conditions. For example, depressed immune response can result in increased incidence of
infection, but heightened immunity may lead to allergies and autoimmunity. Microgravity could
be associated with some impairments of immunity. In flight and ground-based models have
shown that weightlessness impairs signal pathways essential for early T cell activation
(Boonyaratanakornkit et al. 2005). Potential negative health consequences of prolonged immune
dysregulation include hypersensitivity, autoimmunity, infectious diseases and even malignancies.
So, it is important to determine the clinical risk of impaired immunity before initiating long
missions to space.

Genitourinary Problems During Spaceflight
The genitourinary (GU) system is not uncommonly affected during space flight. Almost
50 astronauts out of 508 crew members between 1981 and 1998 reported GU symptoms during
space flights (Jones et al. 2005). GU symptoms can be categorized as: upper tract, lower tract
and reproductive health. GU issues of upper tract during space flight are calculi and related
obstruction. Data collected during short term space flight, long duration Mir missions and
immediately after space flight have revealed increased urinary calcium and a decrease in both
urinary volume and urinary pH resulting in a great risk of kidney stone formation (Whitson et al.
1999). As mentioned earlier, bone loss associated with space microgravity lead to increased
excretion of calcium by the kidneys and increased the urinary supersaturation of stone forming
salts. Several cases of urinary tract infection and retention have also been reported during space
flight. Multiple causative factors could be attributed to urinary tract infection. Stresses,
dehydration, hygiene, and delayed access to voiding could play a role (Whitson et al. 1999).
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Effective countermeasures should be taken since these issues don’t affect astronaut’s health only,
but also affect the success of missions.
With increased durations of space flight missions, an understanding of sex/ gender effects
on reproductive health is needed. Major factors in the space environment that could affect
reproductive health are: radiation, microgravity, and stresses. A 120-day Russian bed rest study
found reduce numbers of active spermatozoa collected after 50-60 and 100 days of the study, and
also an increase in the percentage of morphologically altered spermatozoa (Nichiporuk et al.
1998). One ground-based study of male rats exposed to long duration simulated microgravity by
hindlimb unloading (HU) for 6 weeks reported a significant decline in testicular weights and
spermatogenesis, no spermatogenic cells were present and epididymides were devoid of mature
sperm (Tash et al. 2002). Another HU study documented adverse effects on the tissue that
comprise the walls of the seminiferous tubules and the blood-testis barrier, with these changes
noticeable after only 7 days of HU (Forsman 2012).
With increased involvement of female astronauts in the space program including long
duration space missions, more investigation is required to address the effects of the spaceflight
environment on the female reproductive system. Because female astronauts use hormone
supplements to suppress their menstrual cycles during spaceflight, reproductive changes in
female astronauts have not been studied during or after space flight. The effects of spaceflight
microgravity on menstrual functioning and microgravity induced retrograde menstruation need to
be studied.
Animal studies have provided data on some of the female reproductive changes
associated with exposure to microgravity. Female rats exposed to simulated microgravity using
the HU model have shown lengthening of diestrus phase of the reproductive cycle and therefore
12

lengthening of the estrous cycle (Tou et al. 2004). A prolonged diestrus cycle could result in
reduction in the cumulative number of cycles and thus compromise fertility. Another study used
2g centrifugation to study the effects of hypergravity on the female reproductive system of rats.
This study found delayed conception in centrifuged rats compared to non-centrifuged rats. This
study also showed that both centrifuged and non-centrifuged rats conceived, but centrifuged
females took 3 times longer than non-centrifuged females to achieve conception (Ronca et al.
2005).
A study by Kojima et al. (2000) looked for the effect of simulated microgravity on
mammalian fertilization and embryonic development in vitro using clinorotation. In vitro
fertilization of 80 oocytes and 1x 10^6 sperm/ml were cultured in a microtube under clinostat
rotation and stationary control conditions. Their results indicated that fertilization can occur in a
simulated microgravity condition. But there was a significant decrease in the number of embryos
reaching the morula and blastula stages after 96 hours of embryos culture under clinostat
rotation. Another study investigated the effect of spaceflight on the event of parturition in female
rats. These female rats were in mid pregnancy when flown on either 9 or 11 day long
spaceflights. Each shuttle landed just 2-3 days before parturition. They found that flight female
rats had uncomplicated successful vaginal delivery and delivery occurred at the appropriate
gestational time, however the flight rats had twice the number of lordosis contractions compared
with control group (Ronca and Alberts 2000).
More recent studies have addressed the effect of microgravity on the mammalian female
reproductive system. Mice that were flown for 13 days on the space shuttle Endeavor had a trend
toward thinning of the mucin layer in the uterine tube compared with control group (Svalina and
Forsman 2013). Uterine tissues of female mice flown on the NASA shuttle mission STS-118
had significantly thicker apical mucin layer than control groups (Forsman and Near 2013). The
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thicker mucin layer in flight animals could be attributed to the effect of spaceflight on the
pituitary- gonadal axis which could interfere with LH and FSH production. However, Smith and
Forsman (2012) conducted a study to evaluate the morphological features of the ovaries of these
same animals and found no gross morphological differences in follicle counts and number of
corpora lutea between flight and control animals. Another study found that female mice who
were exposed to 13 days of spaceflight had a thicker layer of mucin lining the vaginal canal than
control mice (Romer and Forsman 2015). According to this study, spaceflight could have
negative effects on sperm survival and may compromise the animal’s ability to reproduce.
Although changes in mucin thickness were documented in these studies, it was unclear whether
or not these changes were due to the microgravity of spaceflight, the radiation of spaceflight, or a
combination of the two.

Ground Based Models to Simulate Microgravity
There are different earth-based techniques used to simulate microgravity and predict
some effects of spaceflight on different body organs and systems. One example of these
techniques is clinorotation via a device known as a clinostat. This device uses rotation to
constantly change the gravitation vector so that the vectors cancel each other rendering no
gravitational vector (Klaus 2001). Other examples are head-down bed rest and water immersion
of humans. The last two techniques mimic the microgravity component of spaceflight because
they induce cephalad fluid shifts and loss of loading on the musculoskeletal system (Epstein
2011; Fortney et al. 2011). The HU model of rodents is the newest technique to simulate
microgravity and weightlessness and it’s the technique used in our experiment so I will explain
this technique in the following paragraph. These earth-based models are very beneficial in space
exploration for several reasons: they are cost effective techniques, provide critical data without
consuming valuable crew time, manipulations can be made with little to no cost increase, and
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allow for variable experimental duration with multiple time points being measured throughout
the experiment. Moreover, unlike spaceflight studies, the experiment can be repeated or extended
as needed and tissues taken from the animal at any time during the experiment.
The HU model has been accepted by the scientific community as the rodent model of
choice to study the adverse effects of spaceflight microgravity and weightlessness on various
body systems, especially the musculoskeletal system. The standard operating procedure for this
technique was updated and approved by the National Aeronautics and Space Administration
(NASA), Ames Research Center (ARC), and Flight Institutional Animal Care and Use
Committee (Flight IACUC) on August 8, 2001. The development of HU model began in 1975
with the results from un-manned spaceflight experiments compared with a HU model. COSMOS
2044, was the first international spaceflight mission that include the HU model in the experiment
as control group (Grindeland et al. 1992; Booth and Grindel 1994). Both spaceflight and the HU
model showed similar but not identical physiological responses in most of the body organs (Vico
et al. 1991; Chapes et al. 1993; Tischler et al. 1993). The physiological responses that the HU
model has to mimic include 1) differential muscle atrophy, 2) cephalad ﬂuid shift, 3) freedom to
move and eat using the forelimbs, and 4) unloading of the hindlimbs without paralysis so that
animals can recover from unloading (Morey-Holton and Globus 2002). There are many
differences between HU simulated microgravity and actual spaceflight microgravity, therefore
care should be taken when comparing results between spaceﬂight and HU experiments. The
entire body is unloaded during spaceflight, while the forelimbs are weight bearing in the HU
model. Therefore, responses in the HU model reflect partial effects of unloading of the
musculoskeletal system on mammalian fertilization and embryonic development. Finally, the HU
group does not experience launch, landing, or transportation to and from the launch and landing
pad.
15

The HU technique as provided by NASA ARC is as follows. HU depends on using tail
traction, surgical pins, or a back harness to unload the hindquarters of rats or mice. This causes
cephalad fluid shifts and removal of gravity forces from hindlimbs, similar to what is seen in
astronauts. Tail traction is used more in the HU model since it is associated with less stress and
there is no need for anesthesia. Handling of the animals begins 1 week before the procedure. The
animals are acclimated to the cages at least 2 days before unloading. It is recommended to avoid
anesthesia, since recovery from anesthesia may affect the animal’s ability to adapt to HU. If
anesthesia is used, then a 24-hour recovery period is needed before the procedure. The procedure
begins with using alcohol to clean the tail and remove dirty or dead skin. The tail is allowed to
dry, then sprayed with strong adhesive and allowed to dry for 1-5 minutes. When the spray is
tacky, a piece of traction tape that was attached to the plastic tab, is attached to the tail, just
above the hair line. The traction tape is then gently pressed to stick to the surface of the tail. Two
strips of filament tape are used to secure the traction tape. One of the ﬁlament tape strips is
secured around the edge of the traction tape at base of the tail, the second strip is placed about
half-way up the traction tape. The filament tape should be loose enough to allow for adequate
blood circulation, while still preventing the traction tape from peeling away from the tail. Gauze
bandage can be wrapped around the base of the tail to protect the traction tape and to prevent the
animal from peeling off the tape. A paper clip is then used to attach the animal to a ﬁsh-line
swivel that hangs from the unloading device on top of the HU cage. The swivel is designed to
prevent only the back feet from touching the cage’s floor while allowing the animal to move
freely using the forelimbs. The animal’s body makes about a 30° angle with the floor of the cage.
A 30° angle of unloading between the cage floor and the torso of the animal is the optimum
degree to simulate spaceflight microgravity as it provides normal weight bearing on the
forelimbs and induces cephalad fluid shifts. As the angle increases, mechanical loading of the
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forelimbs declines and traction on the tail increases. If the angle is too steep, the animals appear
stressed. The cage sides can be adjusted to control the height of the unloading device and allow
the animal to reach food and water. The animal’s overall appearance, activity, and the tail should
be inspected daily to assure the health of the animals

The Nature of Space Radiation
Space radiation consists mainly of three types of radiation: particles trapped in Earth’s
magnetic field, energy from solar particle events, and galactic cosmic rays (GCRs) (NASA Facts.
National Aeronautics and Space Administration, 2002). GCRs are the primary type of space
radiation that astronauts are exposed to on the international space station (ISS), and also on
future space missions. GCRs are considered ionizing radiation. Opposite to non-ionizing
radiation, ionizing radiation has enough energy to knock the electrons out of any atoms it strikes
causing biological changes of exposed cells and tissues. Astronauts are exposed to approximately
50-2000 milliseivert (msv) in 6 months depending if they are on the ISS or the surface of moon
or Mars (Barcellos-Hoff et al. 2015). Since radiation effect studies are difficult to carry out on
human cells and tissues, the risks associated with radiation exposure should be obtained from
ground-based studies using animal models. Ground based studies of radiobiological effects are
largely limited to studies involving survivors of nuclear bombing events in Japan during world
war II, cancer survivors who were exposed to radiation as part of their cancer treatment, and
most recently people exposed to nuclear radiation resulting from nuclear disasters like ones in
the Chernobyl nuclear power plant in Ukraine and the Fukoshima nuclear disaster in Japan.
(Thompson et al. 1994; Cardis et al. 2006; Dörr and Meineke 2011).

Sources and Effects of Radiation Exposure
Radiation is all around us. The sources for ionizing radiation could be natural or manmade. Natural sources of radiation include: cosmic radiation and terrestrial radiation. Terrestrial
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radiation is present in Earth’s crust in natural deposits of uranium and potassium. Natural sources
could also be through inhalation of radioactive gases, such as radon, from the earth soil and
minerals or through ingestion of trace amounts of radiation from some food contents or ground
water (Washington State Department of Health 2002). Some man-made sources of radiation are
used for medical purposes. The best-known application of radiation in the medical field are Xray machines for medical imaging and diagnosis and nuclear medicine which uses radioactive
isotopes to treat cancer (Canadian Nuclear Safety Commission 2012).
Radiation has been shown to have harmful effects on human health. The effect of
ionizing radiation on human health depends on the total dose, exposure rate, and type of tissues
exposed to radiation. The highest effect will be when exposure occurs in large doses over a short
period of time. Some cells are more radiosensitive than others. Cells that are immature,
undifferentiated, and have higher mitotic activity are more radiosensitive than mature, nondividing cells (Goodman 2010). Examples of radiosensitive tissues are blood cells, gonads, lens
of the eye, and skin.
The effect of ionizing radiation on the cellular level can be divided into direct and
indirect damage. DNA is the major target in radiation damage. Ionizing radiation produces a
wide range of DNA lesions, such as base damage, SSBs, double strand breaks (DSBs), and
DNA-DNA and DNA-protein crosslinks (Prise et al. 2005). Base damage and SSBs’ repair occur
via base excision repair and DNA ligation respectively. DSBs have been thought to be the most
relevant lesion for cell killing. Homologous recombination (HR) and non-homologous end
joining (NHEJ) are common repair pathways for DSBs (Jackson 2002). NHEJ is a dominant
pathway in mammalian cells and it is more error prone than HR. Incorrectly repaired or
unrepaired lesions can lead to DNA mutations or cell death. Cell death can occur through
activation of programmed cell death pathways (such as apoptosis and autotrophy) or necrosis
18

(Brown and Rzucidlo 2011). Radiation induced apoptosis occurs through intrinsic pathways
which involve changes in mitochondria or through activation of caspase enzymes that
specifically cleave proteins (Prise et al. 2005).
Absorption of ionizing radiation by cells can generate reactive chemical species (reactive
oxygen species, reactive nitrogen species) that may cause damage to DNA, proteins, and lipids.
This effect of radiation is called indirect effect of radiation and it contributes to more damage
than the direct effect. Because 80% of cellular content is water, ionizing radiation can cause
hydrolysis of water to produce hydrogen molecules and hydroxyl free radical (.OH). Hydroxyl
free radical has an unbound electron and therefore higher affinity to react with other molecules.
When two hydroxyl molecules bind to each other, they form hydrogen peroxide which is highly
toxic (Brown and Rzucidlo 2011).
There are two types of radiation induced injury, stochastic and deterministic (Brown and
Rzucidlo 2011). Deterministic injury occurs once the threshold of radiation exposure has been
exceeded. The severity of deterministic injury increases as the dose increases. Examples of
deterministic effects include skin erythema, cataracts, epilation, and sterility. Acute radiation
syndrome is a form of deterministic injury that occurs when exposed to large doses of radiation
in a short period of time. Signs and symptoms of acute radiation syndrome begin with
gastrointestinal symptoms, nausea, vomiting, diarrhea, and fluid loss. Neurological damage may
occur in larger doses (Dörr and Meineke 2011).
Stochastic effects or long-term effects of radiation are those effects that could appear
years after radiation exposure. These late effects of radiation may result from previous high dose
exposure or from chronic low dose exposure over years. Long term effects could appear as
increased incidence of cancer or hereditary defects. The first reported increase in cancer risk
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associated with radiation exposure was a report in 1944 of a 10-fold increase in leukemia among
radiologists (March 1994). Most of the data about radiation induced cancer comes from
epidemiological studies in human populations receiving radiation exposure from occupational,
medical, and accidental sources. An epidemiological study done 20 years after the Chernobyl
accident showed a dramatic increase in incidence of thyroid cancer (Cardis et al. 2006). Another
epidemiological study on Hiroshima and Nagasaki atomic bomb survivors showed significant
increases in solid tumors in most tissues (Thompson et al. 1994).
RIBE stands for radiation induced bi-standard effect, and is another effect of radiation.
RIBE challenged the conventional dogma that radiation affects only the exposed cells and does
not have any effects on non-exposed cells. RIBE can be defined as the phenomenon in which
irradiated cells can release signaling molecules, which transfer via gap junctions to nonirradiated cells and cause similar toxicity or genetic damage (Han and Yu 2010). By looking at
the radiation effects from epidemiological studies and cancer survivors, we can predict similar or
more sever effects from galactic cosmic radiation on various body organs depending on the
duration the astronauts spend on the international space station, or the surface of the moon or
Mars.

Effect of Radiation on Reproductive Health
Ionizing radiation has effects on gonads. The degree of damage depends on many factors
such as the dose, duration and age of exposure (Goodman 2010). The testis is one of the most
radiosensitive tissues. Radiation exposure to testis occurs through therapeutic, diagnostic, and
occupational exposure. Many studies have investigated the effect of radiation on gonadal
functions. These studies were conducted on cancer survivor patients who were exposed to pelvic
radiation and to people who were exposed to radiation from atomic bombs. Long term studies
investigating the effect of ionizing radiation on testis have shown that reversible azoospermia
20

and decreased levels of testosterone may occur after dose of 0.35 Gy, indicating that radiation
affected Leydig cell function (Rowley et al. 1974). However, a radiation dose above 2 Gy could
cause permanent aspermia (Ogilvy-Stuart and Shalet 1993).
Many studies have also documented the negative effects of radiation on the female
reproductive system. The female reproductive system is highly susceptible to late effects of
radiation exposure. Potential late effects on the female reproductive system can occur as a result
of radiation exposure to the hypothalamic pituitary- ovarian axis (HPO), ovaries, and uterus
(Bath et al. 2002). One of the most common late effects of radiation is ovarian failure as a result
of depletion of the finite number of follicles. One study investigating the effect of total body
irradiation (14 Gy) in childhood and adolescence on ovarian and uterine characteristics has
shown ovarian failure, reduced uterine volume and reduced blood supply to the uterus (Bath et
al. 1999). An ovarian dose of 4 Gy may cause a 30% incidence of sterility in young women, but
100% sterility in women over 40 years of age (Ogilvy-Stuart and Shalet, 1993). 14-30 Gy of
radiation to the uterus is associated with reduced uterine volume, reduced myometrial elasticity,
and some uterine vascular damage (Gnaneswaran et al. 2012). Radiation exposure to the uterus
has also been linked to pregnancy complications such as the increased possibility for
miscarriage, premature delivery, still birth, and low weight birth (Gnaneswaran et al. 2012).

Endometrial Cancer
Endometrial carcinoma, commonly referred to as uterine cancer, is the most common
type of female genital tract cancer in the United States, with approximately 43,470 new cases
diagnosed in the U.S in 2010, and about 7,950 deaths from the disease each year (Naumann
2011). The endometrium consists of an epithelial glandular component and a stromal component.
The endometrium lines the uterine cavity and undergoes changes in response to estrogen and
progesterone. Both stroma and glands proliferate under the influence of estrogen in the first half
21

of the menstrual cycle. In the second half of the cycle, the endometrium differentiates in
preparation for implantation of an embryo under the influence of progesterone. If implantation
does not occur the endometrium sloughs off and the cycle begins again. The endometrium
undergoes well controlled proliferation and differentiation in premenopausal women.
Endometrial carcinoma may arise when hormonal imbalance or genetic alterations affect this
cycle (Di Cristofano and Ellenson 2007).
There are two different pathological types of endometrial carcinoma, type 1 and type 2.
Type 1 arises in women with metabolic and hormonal disturbances such as, obesity,
hyperlipidemia, diabetes, and hyper estrogenic state (Sherman et al. 1997). Type 1 carcinoma is,
also called endometrioid carcinoma. It is moderate to well differentiated (low grade), confined
to uterus (low stage), has favorable prognosis (85% 5-year survival rate), and is often associated
with hyperplasia (Bokhman 1983). Type 2, also called serous carcinoma. It arises in women
where endocrine and metabolic disturbances are absent or unclear. Type 2 are considered poorly
differentiated tumors, with a deep tendency to myometrial invasion. They are estrogen
independent, have doubtful prognosis (58% 5-year survival rate), and appear as atrophic lesions
(Sherman et al. 1997; Bokhman 1983). Type 1 carcinoma is the most common type of the
endometrial carcinoma, representing approximately 85% of cases, while serous carcinoma
represents approximately 10% of cases (Di Cristofano and Ellenson, 2007).

Genetic Alterations Involved in the Development of Uterine Cancer
It has been shown that genetic alterations involved in the development of type 1 cancer
differ from type 2 cancer and each one has a different gene expression profile. Type 1 shows
mutations in the phosphatase and tensin homologue deleted on chromosome 10 (PTEN),
PIK3CA, K-RAS and β-catenin genes. It is also associated with microsatellite instability (MI).
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While type II have loss of heterozygosity (LOH) on several chromosomes and alterations of p53
(Yeramian et al. 2012).
The tumor suppressor gene, PTEN, has been shown to be mutated in a wide variety of
human tumors like brain, breast and prostate cancer and is the most frequently altered gene in
endometrioid carcinoma (Li 1997). PTEN is located on chromosome 10q23. This region of the
genome undergoes loss of heterozygosity in approximately 20-30% of endometrioid endometrial
carcinoma (Di Cristofano and Ellenson 2007). PTEN mutation is also detected in almost of 3761% of endometrioid endometrial carcinoma cases (Yeramian et al. 2012). In contrast to other
tumor types with PTEN mutation, PTEN mutation is observed in endometrial hyperplasia and
thus its mutation occurs early in the pathogenesis of endometrial cancer (Levine et al. 1998).

The PI3K/AKT Pathway
PTEN is the most frequently mutated gene in endometrial cancer and leads to activation
of the PI3K/ AKT pathway and thus malignant transformation (Banno et al. 2012). The PI3K
pathway is the most commonly altered pathway in the pathogenesis of endometrial cancer
(Tashiro et al. 1997). The PI3K pathway transmits growth factor signals from transmembrane
kinase receptors to activate cellular proliferation and survival mechanism. PI3K enzymes are
categorized into three major classes: IA PI3K, IB PI3K, and class II PI3K. Class IA PI3Ks have
been associated with malignant transformation in many cancer types. Class IA PI3Ks exist as
heterodimers made up of a p110 catalytic and p85 regulatory subunit (Naumann 2011). Once the
ligand binds to a tyrosine kinase receptor, a conformational change occurs in p-85 to release its
inhibition of a p-110 catalytic site. Active p-110 converts phosphatidyl inositol 4,5 bi-phosphate
to phosphatidyl inositol 3,4,5-triphosphate(PIP3). This leads to recruitment and activation of
AKT proteins. PTEN acts as a negative regulator of the PI3K pathway by converting PIP3 back
to PIP2, thus preventing AKT recruitment and activation. Therefore, mutation of PTEN leads to
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over activation of PI3K pathway (Osaki et al. 2004). AKT, serine threonine kinase, is one of the
important downstream components of the PI3K pathway. Activated AKT promotes cellular
growth, proliferation, angiogenesis, and prevents apoptosis (Yamaguchi and Wang 2001). There
are three isoforms of AKT proteins, AKT1, AKT2, and AKT3 and they share the same common
structure among different species (Fayard 2005). The AKT proteins consist of three domains; an
N-terminal domain that binds with different proteins on the plasma membrane, a central kinase
domain and a C-terminal regulatory domain (Fayard 2005). Conversion of PIP2 into PIP3 leads
to translocation and recruiting of AKT from the cytoplasm into the plasma membrane to bind
with PIP3 via its N-terminal domain. The activation of AKT is a multistep process that requires
phosphorylation of threonine 308 in the central kinase domain and phosphorylation of serine 473
within the C-terminal regulatory domain. Phospho-inositol dependent kinase (PDK1) is the
enzyme responsible for phosphorylation of threonine 308, while mTORC2 (the mammalian
target of rapamycin complex) is the last candidate kinase that is assumed to be responsible for
phosphorylation of Serine 473 (Naumann 2011). Once activated, AKT acts as the central node of
the PI3K pathway and controls multiple downstream effectors that lead to cellular growth and
proliferation (figure 1).
In this study we conducted immunohistochemical staining employing a pan AKT
antibody which detects all three isoforms of AKT (AKT1, AKT2, AKT3) either in
phosphorylated or non-phosphorylated states. We also used a phospho-AKT antibody in our
Western blot analysis. The phosphor-AKT antibody that we used in western blot detects
phosphorylation sites at serine 473, which is located in the C-terminal regulatory domain of all
AKT proteins. We choose to study this pathway for 2 reasons, first: as mentioned earlier most of
the pathogenesis of endometrial carcinoma involves mutation in the PTEN gene and thus over-
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activation of PI3K, second: radiation and stress seems to activate multiple intracellular signaling
pathways including PI3K pathway and MAPK pathway (Dent et al. 2003).

The MAPK Pathway
The mitogen-activated protein kinase (MAPK) cascade is an intracellular signaling
pathway that regulates different cellular activities including cell growth, cell cycle regulation,
cell survival, angiogenesis, and cell migration. Like the PI3K pathway, the MAPK pathway can
be activated when a ligand binds with a tyrosine kinase receptor on the cell surface or other
receptors like G-protein coupled receptor and cytokine receptors (Friday and Adjei 2008).
The MAPK pathway includes several signaling molecules such as RAS, RAF, MEK, and
ERK. The activation of this pathway begins when a mitogen binds and activates cell membrane
receptor tyrosine kinase causing a downstream signaling cascade. Activated tyrosine kinase leads
to activation of GTPase RAS protein that resides in the plasma membrane and acts as an
upstream switch for activation of other downstream effectors in the MAPK pathway. Activated
RAS leads to recruitment and activation of serine threonine RAF kinases. Active RAF proteins
in turn phosphorylate and activate MEK1 and MEK2. MEK1 and MEK2 are serine/threonine and
tyrosine kinases that activate and phosphorylate extracellular signal regulated kinase (ERK1) and
ERK2. ERK proteins have numerous downstream effectors which regulate cell growth and
proliferation (McCain 2013). Oncogenic alterations in the RAS/MAPK pathway are found in
endometrial cancer in the form of activating KRAS mutations (Duggan et al. 1994). The
mutation of KRAS has been found in 10-30% of endometrial carcinomas (Dobrzycka et al.
2009).
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Figure 1: Overview of The PI3K/AKT and MAPK pathways (Carnero and Paramio 2014).

Objectives and Significance of this Study
There were two major aims of this study:
Specific aim 1: To determine the effect of high radiation exposure and simulated spaceflight
conditions on the incidence of uterine cancer.
Specific aim 2: If cancer is detected, to identify the cell type affected.
Uterine cancer is the fourth most common cancer in women in the United States and the
most commonly diagnosed gynecologic cancer. In 2013, 50,560 women in the United States
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were diagnosed with uterine cancer. 9,325 women in the United States died from uterine cancer
in that year (U.S. Cancer Statistics Working Group 2017). In the United States roughly 1 in 530
people between the ages of 20-39 is a childhood cancer survivor (CureSearch for Children's
Cancer 2018). The unique health related issues faced by these cancer survivors has not been
adequately studied. Irradiation used in the treatment of childhood cancers has been shown to
have long term effects on female reproductive structures, especially the ovary and the uterus.
Exposure to radiation therapy in childhood has impaired uterine function, causing reduced
uterine volume, decreased myometrial elasticity, and some uterine vascular damage
(Gnaneswaran et al. 2012). However, the effect of radiation directly on the reproductive tissue
has not been examined. Disruption to normal reproductive functions are of great public health
concern as they increase the health issues in the mother and cause higher rates of mortality in the
offspring. The space flight environment is also high in radiation. As humans continue venturing
deeper and longer into space, they will be exposed to a high radiation environment. This is
expected to cause effects similar to those seen in clinical irradiation. Our study addressed the
changes associated with radiation and microgravity in female reproductive tissues, especially the
increased risk for uterine cancer.

27

CHAPTER 2
MATERIALS AND METHODS
All tissues utilized in this study came from the laboratories of Drs. Xiao Mao and Mike
Pecaut of Loma Linda University in Loma-Linda, California. Six month old C57 BL/6 female
mice were maintained 4/cage under a constant ambient temperature of 65.8°F with a 12h
light/dark cycle. After 1 week of acclimatization, the animals were randomized into 4 groups
(6/group) as follows: 1) age-matched controls, 2) low-dose-rate (LDR) γ-irradiation, 3)
unloading with tail suspension, and 4) LDR + tail suspension. Cobalt57 (57CO) plates (0.04Gy at
0.01cGy/h) were used to deliver irradiation to the whole body of 6-month-old adult C57 BL/6
mice (n=4-6/group) to simulate the radiation of spaceflight. Anti-orthostatic tail suspension, also
known as HU, was used to model the unloading, fluid shift, and physiological stress aspects of
spaceflight. Mice were hindlimb suspended and/or irradiated for 21 days to test the potential
interaction. In that 21-day unloading period, the mice were individually housed. Mice were
euthanized with 100% CO2. Mice were euthanized either 1 month, 4 months, or 9 months
following completion of treatment (radiation, HU, or radiation combined with HU). Vaginal
smears were performed on each animal at the time of euthanasia to allow estrous cycle stage
determination. Uterine tissues were harvested by a laboratory technician within 30-60 minutes of
euthanasia. Following excision, the uteri were separated into left and right portions. One portion
was placed in RNAlater and the other portion was preserved in 4% paraformaldehyde. The
tissues were then sent to the laboratory of Dr. Allan Forsman at East Tennessee State University.
Upon arriving, paraformaldehyde preserved tissues were trimmed of fat and stored in 70%
ethanol (ETOH). Tissues stored in RNAlater were placed in -80° C storage for later analysis.
Uterine tissues stored in RNAlater were divided into two sections. One section was used
in Western blot analysis while the other section was returned to the RNAlater for future analysis.
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Western Blot Procedure
Uterine tissues were homogenized in 280 µl of RIPA buffer (150 mM NACL, .1% triton
x-100, 0.5% sodium deoxycholate, 0.1% SDS and 50 Mm TrisHCL [ PH 8.0]) with 100 µl
protease inhibitor cocktail (category # B14001), 100 µl phosphatase inhibitor cocktail (category
# B15001-B) and 100 µl phosphatase inhibitor cocktail (category # B15001-A). Homogenate
was centrifuged for 10 min at 16,000 RPM (Revolutions Per Minute) and placed on ice. The
supernatant was then aspirated and placed in a fresh microfuge tube kept on ice. Proteins were
quantified using the Bradford assay. The Bradford protein assay depends on using standard
proteins of known concentration to create standard curves and equations that will be used to
estimate the concentration of protein of unknown solutions. This method is based on the
proportional binding of Coomassie blue dye to proteins. When there are more protein contents in
the solution, more Coomassie dye will bind with protein and create a significant change in color
of the mixture. The Bradford assay uses Coomassie brilliant blue G250 which has a red brown
color in acidic solution, but when proteins bind with this dye the color turns blue. The proteinbound form of the dye has an absorption spectrum maximum at 595 nm. The increase of the
absorbance at 595 nm is positively correlated with the amount of the bound dye and with the
amount of protein in the solution. A spectrophotometer was used to measure the light intensity of
light being absorbed or reflected and express these intensities in the form of absorbance values.
For this assay we used the dye reagent and protein assay standards which are set at seven
prediluted concentrations (1000, 500, 250, 125, 62.5, 31.25, 15.625 µg/µl). The first step in
protein quantification is dilution of protein samples with distilled water then vortex. This step
was necessary because homogenization was done in RIPA buffer and RIPA buffer interferes
with the protein-dye interaction. Because of this interference the protein samples should undergo
a 40 – 50 X dilution before beginning the protein estimation. To accomplish this, 245 µl of
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distilled water was added to 5 µl protein samples. Then 30 µl of diluted protein samples and
standards were added to the wells of assay plate. For accuracy this last step was performed in
triplicate. For each well containing the samples and the standards, 270 µl of Coomassie plus (pro
# 1856209) was added and incubated for 10 minutes at room temperature. A spectrophotometer
was used to read the plate and obtain the readings of standard protein concentration versus the
absorbance. A standard curve calculated from the readings of the standards was used to predict
the concentration for our protein samples.
To prepare samples for western blotting, the sample tubes were placed in a hot plate at
100℃ for 5 minutes, placed on ice for 5 minutes, then vortex and spun. An equal amount of
protein was loaded into the wells of TGx pre-cast gels (category # 456-1086, lot # 64074007). 5
µl of ladder was added to the first lane (category # 26616) and 15 µl of each sample was added
to the remaining lanes. The container was filled with running buffer and the gel was run at 300
volts for 25 minutes. Protein was transferred to an Immobilon polyvinylidene fluoride (PVDF)
membrane over 1 hour using 100 V. After 1 hour the membrane was stained with ponceau red to
check the transfer quality. The membranes were then washed with TBS-T 3x for 5 minutes, then
blocked in 10 ml western blot blocking (TBS, 2% bovine serum albumin, 2% fetal calf serum,
0.1% sodium azide) for 1 hour. Membranes were exposed to a 1:1000 primary antibodies (10 ml
of TBST, 10 µl of phospho AKT, and 10 µl of 20% sodium azide) of rabbit anti- mouse phospho
AKT (cat # 4051). Membranes were washed with TBS-T three times for five minutes. Then
membranes were incubated with appropriate 1:10000secondary antibodies (2.5 µl of goat anti
rabbit #31460, 0.5 g of non-fat milk, 25 ml of TBST) coupled to horse radish peroxidase (HRP)
for 1 hour at room temperature. After washing the membranes three times for 5 minutes, signals
were visualized using chemiluminescent lumigen (100 µl of reagent A, 100 µl of reagent B and 1

30

ml of distilled water). Then we used alpha view software to read the band intensity of the target
proteins.
Membranes were stripped using mild stripping buffer for 10 minutes, PBS was added two
times for 10 minutes and poured off, then TBS-T was added two times for 5 minutes and poured
off. Membranes were blocked again with western blot blocking buffer. Membranes were then
ready for application of other primary antibodies such as rabbit anti- total AKT (468S), rabbit
phospho mapK 42/44 (Cat # 4370), total 42/44 ERK, and β-tubulin. β-tubulin was used as a
housekeeping protein to do normalization with target proteins. Membranes were incubated for 1
hour with appropriate secondary antibody (goat anti mouse #7076s or goat anti rabbit #31460).

Histological Examination
Paraformaldehyde preserved uterine horns were divided into proximal, middle, and distal
portions. The middle portion was embedded in paraffin for use in this study. The first step in
tissue processing is tissue dehydration. Because paraffin is immiscible in water, tissue
dehydration is required to remove water from tissues before paraffin infiltration is performed.
Paraffin embedding is necessary to render the tissue firm enough to be sectioned on a
microtome. In order to infiltrate the tissue with paraffin the water/fluid component of the cell
must be replace with melted paraffin. This is accomplished by immersing the tissue in increasing
concentrations of ETOH until the tissue is infiltrated with 100% ETOH. To accomplish this
infiltration the tissue is removed from the 70% ETOH in which it was stored and placed on 80%
ETOH for 30 minutes. The tissue is then moved to 90%, ETOH, 95% ETOH, 95% ETOH, and
finally 100% ETOH for 30 minutes each, with the 100% stage done twice. This gradual
dehydration prevents distortion and damage of the cells/tissue. Because ETOH is not miscible
with paraffin, further steps must be taken to replace the ETOH with melted paraffin. This is
accomplished by immersing the tissue in a 50:50 mixture of 100% ETOH and a dehydrating
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agent known as Citrisolv for 30 minutes. It should be noted that Citrisolv is miscible with both
ETOH and paraffin. Following this 30-minutes immersion the tissue is place in 100% Citrisolv
for 30 minutes followed by immersion in a 50:50 mixture of Citrisolv and melted paraffin. This
stage, and all subsequent stages must be carried out at 60-65°C to insure the paraffin remains
liquid. The tissue is then immersed in 100% paraffin for 1 hour followed by another 1-hour
immersion in another container of 100% paraffin. Following the second hour of 100% paraffin
immersion the paraffin is placed in an embedding mold that has been treated with mold release.
Mold release is made of a solution consisting of 5 ml of glycerin and 400 ml of 75% ETOH.
Embedding molds are treated by immersion in mold release and then allowing to dry and then
repeating this step. The remaining steps in the embedding procedure are carried out on a tissueTek embedding console. One the tissue is place in the embedding mold a small amount of melted
paraffin is dispensed into the embedding mold and the tissue is centered in the embedding mold.
Once the tissue is in the desired position the embedding mold is moved to the cooling plate of the
console and an embedding ring is added to the top of the embedding mold. Melted paraffin is
then added to the embedding ring until the ring is filled. The embedding mold/ring assembly is
then moved to the final cooling area of the embedding console and the paraffin allowed to
cool/solidify. Once solidified the tissue/block can be stored indefinitely.
Embedded tissues were then sectioned at 4µm and placed on glass microscope slides.
Slides were then stained using a standard H&E staining technique. The slides were examined
microscopically for visible signs of cancer.
For immunohistochemical (IHC) staining we prepared three microscopic slides for each
specimen. Two slides had the primary and secondary antibodies, while the third slide had
negative control, or had primary or secondary antibody only. The primary antibody used in this
procedure was a pan-AKT antibody (cat#8805). IHC staining was used to identify the presence
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and location of AKT in these tissues. The first step in IHC was deparaffinizing and rehydrating
the tissue sections using xylene and series of alcohol concentrations. Paraffin should be removed
to expose the epitope and allow its binding with primary antibody. Also, failure to remove
paraffin will trap excess chromogen causing background staining. Rehydration will be important
to allow the target antigen to interact with antibodies. Deparaffinization is accomplished by
immersing microscopic slides twice in xylene for 3 minutes each. Then slides are immersed in
series of alcohol concentrations for rehydration. The slides immersed in 100% ETOH, 95%
ETOH, 80% ETOH, and 70% ETOH for 3 minutes each with 100% stage done twice. Finally,
tissues were immersed in distilled water 3 times for 3 minutes each.
Microscope slides were then placed in a container filled with tap water and transferred to an
autoclave for 15 minutes at 122°C of wet cycle. This step was done to retrieve and unmask the
antigen binding sites that were crosslinked during the paraformaldehyde fixation. Following
antigen retrieval 3% hydrogen peroxide was applied to each slide to prevent endogenous
peroxidase activity and therefore prevent nonspecific binding and false positive detection. This
blocking step was performed at room temperature for 45 minutes. Slides were then rinsed with 1X rinse buffer (LOT# 2834466). To prepare 100 ml of 1X rinse buffer we added 5 ml of 20X
rinse buffer from the IHC kit, 95 ml of distilled water, and added 100 µl of tween 20. To prevent
nonspecific binding of primary and secondary antibodies with non- antigen proteins, we applied
2 drops of blocking reagent to the specimen and incubated at room temperature for 45 minutes in
an enclosed container. The slides were then rinsed with 1X rinse buffer. Two types of blocking
solution were used during the procedure, blocking reagent in IHC kit (LOT# 2834466) which
was later replaced with carrier solution (1 ml of normal goat serum, 1.5 grams of bovine serum
albumin, 1.5ml of 20% triton X-100, and 97.5 ml of PBS). Normal serum carries antibodies that
will bind to the non-specific epitopes in the sample, thus preventing non-specific binding with
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primary antibody. A serum identical to the host animal of the secondary antibody or from an
unrelated species is recommended to prevent interactions with primary or secondary antibodies,
or with the tissues/cells being stained.
Two drops of blocking solution were added per slide and the slides subsequently
incubated for 45 minutes at room temperature. The next step was rinsing and applying primary
antibody 1: 1000 (1 µl of p-AKT cat # 8805, 998.5 µl of PBS, and 0.5 µl of tween 20). Primary
antibody was applied at 4°C overnight. The slides were then rinsed with 1X rinse buffer.
Secondary antibody was applied for 45 minutes at room temperature. The antigen bound
antibody was then localized by adding streptavidin HRP (two drops for 45 minutes) which
generates amplified signal when chromogen reagent is added. The IHC kit we used contained
two bottles of chromogen reagent, DAB chromogen A and B. We mixed chromogen A and B in
a 1:25 ratio and applied to the slides for ten minutes then rinsed. Hematoxylin counterstain was
applied for 1 minute, rinsed, and placed in container filled with tap water. The counterstain
provides contrast to primary stain and helps to pin point the exact position of positive staining
cells. The last step in IHC was sealing the sample and prevent enzymatic produced solubilization
by dehydration through a graded series of alcohol and xylene based mounting media (paramount)
followed by cover slipping. Dehydration is accomplished by immersing slides in 70% ETOH,
80% ETOH, 95% ETOH, 100% ETOH for two minutes each with the 100% ETOH stage done
twice. Then slides are immersed twice in citrisolv for 3 minutes each and then cover slipped.
To evaluate the IHC results, the slides were scored in triplicate (each slide was read three
times by the same observer) using the combined location and intensity scoring system, where a
score of 0 indicates no staining reaction or weak focal reaction, a score of 1 for intense focal or
mild diffuse reaction, a score of 2 for moderate diffuse reaction, and a 3 for intense diffuse
reaction (Fedchenko and Reifenrath 2014).
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Statistical Analysis
Relative band densities of western blots were calculated for each protein of interest using
alpha view software. These were normalized to β-tubulin controls for graphical depiction of
western blot results. Graph Pad Prism 7 was used for the statistical analysis and generation of
graphs. Data were summarized by the mean and standard deviation. Group mean responses were
compared by one-way analysis of variance (ANOVA) where p-values of 0.05 or smaller were
considered significant.
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CHAPTER 3
RESULTS

Gross Morphology of H&E Stained Uterine Tissues
To investigate possible uterine morphological and structural changes induced by
simulated microgravity, whole body radiation, or the two-combined, hematoxylin and eosin
(H&E) staining of the uterine tissues was performed. The gross morphology of the H&E stained
tissues was microscopically evaluated. Represented examples of these stained tissue can be seen
in figure 2. Results of the H&E staining revealed no differences between these samples at the
gross morphological level. No indication of abnormal sizes or shapes of cells or abnormal
growth was noted.
Figure 2A

Figure 2B

Figure 2C

Figure 2D

Figure 2: Longitudinal section of H&E stained uterine tissues from the animals sacrificed 9months post treatment (X100) for A) control mouse, B) radiated mouse, C) unloaded mouse, and
D) radiated and unloaded mouse.
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Immunohistochemical Evaluation
To investigate the possible cancer-causing effects of whole body radiation, HU, or a
combination of the two on uterine tissues, we used immunohistochemical staining (IHC) using a
pan AKT antibody. The IHC staining results show that uterine tissues from animals sacrificed 4
months post treatment had mild diffuse expression of AKT. There was no difference between the
control and other treatment groups as seen in figure 3.
Figure 3A

Figure 3B

Figure 3C

Figure 3D

Figure 3: Longitudinal section of IHC stained uterine tissues from the animals sacrificed 4months post treatment (X100) for A) control mouse, B) radiated mouse, C) unloaded mouse, and
D) radiated and unloaded mouse.

There is no difference in AKT expression level between the various treatment groups in
the tissues from the animals sacrificed 9 months post treatment. However, the positive staining
reaction was moderate to intense diffuse compared with the various treatment groups in the
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tissues from the animals sacrificed 4 months post treatment as shown in figure 4. IHC staining
results also show that AKT expression was visible in both the endometrial and myometrial layers
of the uterus as shown in figure 4E.
Figure 4A

Figure 4B

Figure 4C

Figure 4D

Figure 4E

Figure 4: Longitudinal section of IHC stained uterine tissues from the animals sacrificed 9months post treatment (X100) for A) control mouse, B) radiated mouse, C) unloaded mouse, D)
radiated and unloaded mouse, E) and R/UN section show AKT positive staining in both
endometrial and myometrial layers.

38

Western Blot Analysis
Expression of pAKT in 4 Months and 9 Months Post Treatment Uterine Tissues
To investigate whether or not whole-body radiation, HU, or the combination of the two
causes over activation of the PI3K pathway, western blot analysis was performed to identify the
level of pAKT proteins in 4 months and 9 months post treatment samples. There was no
significant difference of pAKT protein level normalized data between control, HU, radiated, and
radiated and unloaded groups in both 4 months and 9 months post treatment samples as seen in
figures 5 and 6.
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Figure 5: pAKT content in uterine samples from animals sacrificed 9 months post treatment. A:
Representative Western blot of Uterine pAKT protein; B: Densitometry of the ratio of pAKT
bands to total AKT. No statistical difference between groups (p = 0.82). Data was expressed as
the mean ± SD (n = 3 mice/group).
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Figure 6: pAKT content in uterine samples from the animals sacrificed 4 months post treatment.
A: Representative western blot of Uterine pAKT protein level; B: Densitometry of pAKT bands
normalized to β-tubulin. No statistical difference between groups (p = 0.11). Data are expressed
as the mean ± SD (n = 2-3 mice/group).
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Expression of pMAPK in 4 Months and 9 Months Post Treatment Uterine Tissues
To investigate whether or not radiation, HU, or a combination of the two over activate the
MAPK pathway, western blot analysis was performed to identify the level of phospho ERK and
total ERK from the animals sacrificed 4 months and 9 months post treatment. Western blot
analysis revealed no significant difference of phospho ERK normalized data among control,
unloaded, radiated, and radiated and unloaded groups (p>0.05) as seen in figures 7 and 8.
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Figure 7: pERK content in uterine samples from the animals sacrificed 9 months poste treatment
A: Representative Western blot of Uterine pERK protein level; B: Densitometry of the ratio of
pERK bands to total ERK. No statistical difference between groups (p =0.99). Data was
expressed as the mean ± SD (n = 3 mice/group).
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Figure 8: pERK content in uterine samples from the animals sacrificed 4 months poste
treatment. A: Representative Western blot of Uterine pERK protein level; B: Densitometry of
pERK bands normalized to β tubulin. No statistical difference between groups (p = 0.34). Data
was expressed as the mean ± SD (n = 2-3 mice/group).

42

CHAPTER 4
DISCUSSION AND CONCLUSIONS
This study was designed to investigate whether radiation, simulated microgravity or both
may increase the incidence of uterine cancer, and if so, which portion/s of the uterus,
endometrium or myometrium, are more vulnerable. Experimental studies using animal models
and epidemiological studies of atom bomb survivors and survivors of nuclear accidents have
shown radiation to be a universal carcinogen (Little 2000). The carcinogenic effect of radiation
comes from radiation’s ability to penetrate protective cellular barriers and deposit energy inside
cells. Radiation is known to cause cancer by one of three mechanisms: alteration in the structure
of genes or chromosomes, alteration in gene expression, or through oncogene viruses (Beir
1990).
PI3K and MAPK pathways are common intracellular pathways that have been shown to
be activated in uterine cancer (Yeramian et al. 2012). The PI3K pathway activation begins when
a ligand binds to tyrosine receptor kinase causing PI3K enzyme to convert PIP2 into PIP3. This
leads to recruitment of a cytosolic inactive form of AKT to the plasma membrane where it binds
with PIP3. AKT binding with PIP3 induces conformational changes of AKT which enables its
activation by various kinases in the plasma membrane. PDK1 enzyme phosphorylates AKT at
threonine residue, while mTORC2 directly phosphorylates the serine residue of AKT. This
double phosphorylation fully activates AKT. AKT is one of the major downstream effectors of
the PI3K pathway. Activated AKT in turn activates other effectors important for cell growth and
proliferation. The PTEN gene, which is highly mutated in uterine cancer, acts as negative
regulator of the PI3K pathway by conversion PIP3 back into PIP2 which prevents AKT
recruitment and activation.
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In this study, pAKT levels were measured using western blot analysis. No significant
difference in normalized level of pAKT to β-tubulin or in relative level of pAKT to total AKT
was noted in the different treatment groups utilized. The treatment groups utilized included
animals sacrificed 4 months and 9 months after total body radiation, HU or both.
The MAPK pathway has been shown to be activated under the effect of radiation and
stress conditions. Also, the MAPK pathway has been found to be upregulated in 10-30% of
endometrial cancer. Like the PI3K pathway, activation of the MAPK pathway begins when a
ligand binds to the membrane tyrosine kinase receptor, causing a downstream signaling cascade.
pERK is one of the downstream effectors of the MAPK pathway. Phosphorylated ERK activates
other proteins, which have an important role in cell growth and survival.
In this study, the pERK level was measured using western blot analysis. No significant
difference in pERK normalized to β-tubulin level or relative to total ERK were noted in the
different treatment groups utilized. The treatment groups utilized included animals sacrificed 4
months and 9 months after total body radiation, HU or both.
The western blot analysis results were consistent with hematoxylin and eosin (H&E)
stained uterine tissues. H&E staining of uterine tissues was performed to detect any possible
abnormal changes at the gross morphological level under the effect of whole body radiation,
microgravity, or both. The results of H&E stained uterine tissues show no morphological
differences between the treatment groups in animals sacrificed 4 months and 9 months after total
body radiation, HU or both.
An IHC staining technique was also used to determine the expression level of AKT
proteins in uterine tissues. Pan AKT primary antibody was used in the IHC staining technique.
Pan AKT antibody detects the AKT proteins either in phosphorylated or non-phosphorylated
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states. The results of IHC show mild diffuse staining of pan AKT in uterine tissues. No
difference between treatment groups of animals sacrificed 4 months after total body radiation,
HU or both was detected. IHC staining results for uterine tissues from animals sacrificed 9
months after whole body radiation, unloading, or both show more intense staining of pan AKT
compared to 4 months treatment groups.
These results indicate that small dose 0.04 Gy (40 milliseivert) whole body gamma
irradiation, HU, or both dose not induce the formation of uterine cancer formation. The fact that
ionizing radiation causes cancer in humans has been documented. By 1902, the first radiation
induced cancer was reported as skin cancer and the first report of radiation induced leukemia
occurring in five radiation workers appeared in 1911 (Little 2000). These findings of radiation
carcinogenesis were further supported by experimental studies of animal models and by long
term follow up studies of atomic bomb survivors. These studies also documented the fact that
radiation is a relatively weak carcinogen and mutagen compared with other chemicals, but its
effect can be modulated significantly by other secondary factors (Beir 1990).
Carcinogenesis is a multistep process which involves interaction of many external
(chemical and physical) and endogenous factors such as age, sex, genetic background, and
immunologic status (Beir 1990). The multistage model of carcinogenesis indicates that cancer
formation requires 3 steps: initiation, promotion, and progression.
The initiation process is irreversible. The radiation is considered an initiator of cancer.
The ability of radiation to initiate cancer could be attributed to the wide spectrum of DNA
lesions. It is well documented that the main target of radiation is DNA, which is damaged by the
radiation. Radiation causes a wide spectrum of DNA lesions including damage to nucleotides,
SSBs, and DSBs. DSBs are considered the primary lesion in the induction of gene mutation and
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chromosomal aberrations (Mullenders et al. 2009). DSBs are repaired mainly via error prone
NHEJ.
The second process of carcinogenesis is promotion. This stage is reversible and requires
stimulation of cell division. Ionizing radiation could be a promotor if given at high enough dose.
Whereas the initiating agents, radiation, are carcinogenic by themselves if they were given in a
large dose, promoting agents must be given repeatedly to over a long period of time, during
which successive promotion may occur (Beir 1990; Little 2000).
Progression is the third stage of carcinogenesis. This stage occurs when additional
genetic alterations allow the cell to be invasive and metastatic. Ionizing radiation could progress
cancer formation due to its ability to deactivate tumor suppressor genes. This multistage nature
of carcinogenesis indicates that radiation is a contributing factor and by its interaction with
various secondary factors can lead to cancer progression.
Most studies investigating the relationship between radiation and cancer risk have looked
at people who were exposed to high levels of radiation. It is more difficult to measure the risk of
cancer after exposure to lower doses of radiation. Thus, whether low dose of ionizing radiation
LDIR is a risk factor for cancer remains controversial (Mullenders 2009). A study done by
Zhang et al. (2015) using a mouse model has revealed that a risk of mammary cancer from low
dose radiation depends greatly on the genetic makeup of these mice. According to this study,
cancer susceptibility is a complex process that depends on interaction between multiple factors,
such as exposure to low dose radiation, genetic background, and the tumor microenvironment
(immune, endocrine, and vascular system). They identified 13 genetic loci which contribute to
tumor susceptibility when a mouse is exposed to radiation. Further research is needed to identify
how these genetic loci affect cancer development. According to Zhang’s study, cancer risk from
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exposure to low dose radiation differs among individuals. Therefore, one individual may have a
higher risk to cancer after radiation exposure than another individual according to their genetic
makeup.
AKT, serine/threonine kinase, is considered one of the most critical regulators of cell
cycle control, apoptosis, and metabolism. AKT is central to many human physiological
processes, but an increase of function of AKT is linked to multiple diseases. An example of
pathological involvement of PI3K pathway is a study done by Suman et al. (2012) investigated
the effect of radiation exposure on mammary tissues. The researchers exposed mice to 2 Gy
whole body gamma radiation. The results showed increase incidence of breast cancer. According
to this study, radiation lead to increase expression of estrogen which binds to estrogen receptor
alpha (ERα) resulting in activation of PI3K pathway. Western blot analysis of the uterine tissues
in our study shows a clear band for pAKT in all treatment groups without significant differences.
AKT plays a physiological role in uterine tissue regulating factors related to cell death and
proliferation, such as embryo implantation, decidualization, and menstruation (Fabi and Asselin
2014).
ERK proteins play a significant role not only in pathological processes but also in
different physiological processes such as proliferation, differentiation and development (Shaul
and Seger 2007). The physiological role of the PI3K and MAPK pathways in the uterus involve
functions related to tissues remodeling that occur during the menstrual cycle and during embryo
implantation. Cell migration is an example of physiological processes used by cells during
several processes such as wound healing. The endometrium is plastic tissue which undergoes
adaptive reactions to the physiological changes that occur in different phases of the
menstrual/estrous cycle and during embryo implantation (Gentilini et al. 2007). When
endometrial tissue loss occurs during menstruation, endometrial cell growth, angiogenesis, and
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cell migration act together to reestablish organ integrity and refill the space created by tissue
loss. According to the study of Gentilini et al. (2007) MAPK and PI3K pathways are activated in
response to growth factors and cytokines and have important role in cell migration and growth
during endometrial remodeling. These proteins are expressed normally in uterine tissues in order
to perform necessary physiological functions. This could explain the visible bands of pERK and
pAKT in the western blots of our uterine tissues.
IHC staining results showed more intense staining for AKT proteins in animals sacrificed
9 months post treatment compared to animals sacrificed 4 months post whole body radiation,
microgravity, or both. This may indicate higher level of AKT proteins in 9 months samples
compared to 4 months samples. Animals sacrificed 9 months post whole body irradiation,
microgravity, or both may live enough time to show cellular changes after treatment. This may
indicate higher cellular activity in 9 months treatment groups which could be indicative for
abnormal changes or hyperplasia in uterine tissues. Further research using more quantitative
methods is needed to explain this increase.
Linear energy transfer (LET) is the energy transferred per unit length of track. Low LET
radiation travel longer distance through matter and deposits less energy. High LET radiation
deposits large amount of radiation in a small distance. So, high LET radiation causes more
cellular damage than low LET radiation (Cucinotta and Durante 2006). Spaceflight radiation is
considered high LET, while X-rays and gamma rays are low LET radiation. The main health
concerns of astronaut’s health are exposure to space radiation. Space radiation includes high
charge and energy protons (HZE) and secondary radiation produced by nuclear reaction in space
craft walls or in tissues. The possible mission to mars could result in whole body radiation dose
of about 1 Sievert or more.
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Studies have shown that high LET radiation produces different DNA lesions and complex
breaks compared with low LET radiation (Cucinotta and Durante 2006). Complex damage
occurs within a localized region of DNA making the repair more difficult. This will cause more
complex chromosomal rearrangement which may lead to cancer formation or cell death. Being
limited in its ability to accurately simulate the radiation component of spaceflight and therefore,
although we did not see any incidence of uterine cancer, this would not preclude astronauts
exposed to higher energy radiation from developing uterine cancer. Some future aims in working
on this project include using higher level of radiation dose and studying the effect of radiation,
microgravity, or both directly on the PTEN and KRAS genes.

49

REFERENCES
Banno K, Kisu I, Yanokura M, Tsuji K, Masuda K, Ueki A, Kobayashi Y, Yamagami W,
Nomura H, Tominaga E, et al. 2012. Biomarkers in endometrial cancer: Possible clinical
applications (Review). Oncology Letters, 3(6), pp.1175-1180.
Barcellos-Hoff M, Blakely E, Burma S, Fornace A, Gerson S, Hlatky L, Kirsch D, Luderer U,
Shay J, Wang Y, et al. 2015. Concepts and challenges in cancer risk prediction for the
space radiation environment. Life Sciences in Space Research, 6, pp.92-103.
Bath L, Critchley H, Chambers S, Anderson R, Kelnar C, Wallace W. 1999. Ovarian and uterine
characteristics after total body irradiation in childhood and adolescence: response to sex
steroid replacement. BJOG: An International Journal of Obstetrics and Gynaecology,
106(12), pp.1265-1272.
Bath L, Wallace W, Critchley H. 2002. Late effects of the treatment of childhood cancer on the
female reproductive system and the potential for fertility preservation. BJOG: An
International Journal of Obstetrics and Gynaecology, 109(2), pp.107-114.
Beir V. 1990. Health effects of exposure to low levels of ionizing radiation. Choice Reviews
Online, 28(01), pp.0330-0330.
Bokhman J. 1983. Two pathogenetic types of endometrial carcinoma. Gynecologic Oncology,
15(1), pp.10-17.
Boonyaratanakornkit J, Cogoli A, Li C, Schopper T, Pippia P, Galleri G, Meloni M, HughesFulford M. 2005. Key gravity-sensitive signaling pathways drive T cell activation. The
FASEB Journal, 19(14), pp.2020-2022.
Booth FW, Grindeland RE. 1994. Comparison of the physiology of the spaceﬂight and hindlimb
suspended rat. In: Final Reports of the U.S. Experiments Flown on the Soviet Biosatellite
Cosmos 2044, NASA TM 108802, pp.275–281.
Brown K, Rzucidlo E. 2011. Acute and chronic radiation injury. Journal of Vascular Surgery,
53(1), pp.15S-21S.

50

Canadian Nuclear Safety Commission. 2012. Introduction to Radiation (ISBN 978-1-100-215723). Canada: Canadian Nuclear Safety Commission.
Cardis E, Howe G, Ron E, Bebeshko V, Bogdanova T, Bouville A, Carr Z, Chumak V, Davis S,
Demidchik Y, et al. 2006. Cancer consequences of the Chernobyl accident: 20 years on.
Journal of Radiological Protection, 26, pp.127–140.
Carmeliet G, Nys G, Stockmans I, Bouillon R. 1998. Gene Expression Related to the
Differentiation of Osteoblastic Cells Is Altered by Microgravity. Bone, 22(5), pp.139S143S.
Carnero A, Paramio JM. (2014). The PTEN/PI3K/AKT pathway in vivo, cancer mouse models.
Front Oncol, 4(252), pp.1-10.
Chapes S, Mastro A, Sonnenfeld G, Berry W. 1993. Antiorthostatic suspension as a model for
the effects of spaceflight on the immune system. Journal of Leukocyte Biology, 54(3),
pp.227-235.
Charles J, Lathers C. 1991. Cardiovascular Adaptation to Spaceflight. The Journal of Clinical
Pharmacology, 31(10), pp.1010-1023.
Clément G. 2011. The Musculo-Skeletal System in Space: Fundamentals of Space Medicine, 23,
pp.181-216.
Convertino V. 2009. Status of cardiovascular issues related to space flight: Implications for
future research directions. Respiratory Physiology & Neurobiology, 169, pp. S34-S37.
Crucian B, Stowe RP, Ott CM, Becker JL, Haddon R, McMonigal KA. 2009. Risk of Crew
Adverse Health Events Due to Altered Immune Response. Houston, TX: NASA Johnson
Space Center, 32.
Cucinotta F, Durante M. 2006. Cancer risk from exposure to galactic cosmic rays: implications
for space exploration by human beings. The Lancet Oncology, 7(5), pp.431-435.
CureSearch for Children's Cancer. 2018. Retrieved from https://curesearch.org/ChildhoodCancer-Statistics.

51

Dent P, Yacoub A, Contessa J, Caron R, Amorino G, Valerie K, Hagan M, Grant S, SchmidtUllrich R. 2003. Stress and Radiation-Induced Activation of Multiple Intracellular
Signaling Pathways1. Radiation Research, 159(3), pp.283-300.
Derrickson BH, Tortora GJ. 2013. Principles of Anatomy and Physiology, 14th Edition.
Hoboken, New Jersey: Wiley. pp.820.
Di Cristofano A, Ellenson LH. 2007. Endometrial carcinoma. Annual Review of Pathology, 2,
pp. 57–85.
Di Prampero P, Narici M. 2003. Muscles in microgravity, from fibers to human motion. Journal
of Biomechanics, 36(3), pp.403-412.
Dobrzycka B, Terlikowski S, Mazurek A, Kowalczuk O, Niklińska W, Chyczewski L,
Kulikowski M. 2009. Mutations of the KRAS oncogene in endometrial hyperplasia and
carcinoma. Folia Histochemica et Cytobiologica, 47(1).
Dörr H, Meineke V. 2011. Acute radiation syndrome caused by accidental radiation exposure therapeutic principles. BMC Medicine, 9(126), pp.1-6.
Drake RL, Vogl W, Mitchell AW. 2015. Grays basic anatomy. Philadelphia, PA: Elsevier.
pp.277.
Duggan BD, Felix JC, Muderspach LI, Tsao JL, Shibata DK. 1994. Early mutational activation
of the c-Ki-ras oncogene in endometrial carcinoma. Cancer Research, 54(6), pp.1604–
1607.
Epstein M. 2011. Renal, Endocrine, and Hemodynamic Effects of Water Immersion in Humans.
Comprehensive Physiology, pp.845–853.
Fabi F, Asselin E. 2014. Expression, activation, and role of AKT isoforms in the uterus.
Reproduction, 148(5), pp.R85-R95.
Fayard E. 2005. Protein kinase B/Akt at a glance. Journal of Cell Science, 118(24), pp.56755678.

52

Fedchenko N, Reifenrath J. 2014. Different approaches for interpretation and reporting of
immunohistochemistry analysis results in the bone tissue – a review. Diagnostic
Pathology, 9(1), pp.221-232.
Forsman AD, Nier HA. 2013. The effects of spaceflight on mucin production in the mouse
uterus. Gravitational and Space Research, 1(1), pp.20-28.
Forsman AD. 2012. The effects of simulated microgravity on the seminiferous tubules of
rats. Advances in Space Research, 49(4), pp.807-811.
Fortney S, Schneider V, Greenleaf J. 2011. The Physiology of Bed Rest. Comprehensive
Physiology, pp.889-939.
Friday B, Adjei A. 2008. Advances in Targeting the Ras/Raf/MEK/Erk Mitogen-Activated
Protein Kinase Cascade with MEK Inhibitors for Cancer Therapy. Clinical Cancer
Research, 14(2), pp.342-346.
Gentilini D, Busacca M, Di Francesco S, Vignali M, Viganò P, Di Blasio A. 2007. PI3K/Akt
And ERK1/2 signalling pathways are involved in endometrial cell migration induced by
17β-estradiol and growth factors. MHR: Basic science of reproductive medicine, 13(5),
pp.317-322.
Gmünder FK, Konstantinova I, Cogoli A, Lesnyak A, Bogomolov W, Grachov AW. 1994.
Cellular immunity in cosmonauts during long duration spaceflight on board the orbital
MIR station. Aviation, Space, and Environmental Medicine, 65(5), pp.419-423.
Gnaneswaran S, Deans R, Cohn R. 2012. Reproductive Late Effects in Female Survivors of
Childhood Cancer. Obstetrics and Gynecology International, 2012, pp.1-7.
Goodman TR. 2010. Ionizing Radiation Effects and Their Risk to Humans. American College of
Radiology, November 2010, pp. 1-4.
Grindeland RE, Ballard RW, Connoly JP, Vasquez MF. 1992. COSMOS 2044 mission Overview. Journal of Applied Physiology, 73, 1S-3S.
Han W, Yu KN. 2010. Ionizing Radiation, DNA Double Strand Break and Mutation. Advances
in Genetics Research, 4, pp.1-13.
53

Hawkins W, Zieglschmid J. 1975. Clinical aspects of crew health. NASA STI, Biomedical Results
of Apollo, pp.43-81.
Jackson S. 2002. Sensing and repairing DNA double-strand breaks. Carcinogenesis, 23(5),
pp.687-696.
Jones J, Jennings R, Pietryzk R, Ciftcioglu N, Stepaniak P. 2005. Genitourinary issues during
spaceflight: a review. International Journal of Impotence Research, 17(S1), pp.S64-S67.
Klaus DM. 2001. Clinostats and bioreactors. Gravitational Space Biol Bull, 14, pp.55–64.
Kojima Y, Sasaki S, Kubota Y, Ikeuchi T, Hayashi Y, Kohri K. 2000. Effects of simulated
microgravity on mammalian fertilization and preimplantation embryonic development in
vitro. Fertility and Sterility, 74(6), pp.1142-1147.
Lang T, LeBlanc A, Evans H, Lu Y, Genant H, Yu A. 2004. Cortical and Trabecular Bone
Mineral Loss from the Spine and Hip in Long-Duration Spaceflight. Journal of Bone and
Mineral Research, 19(6), pp.1006-1012.
Leach C, Inners L, Charles J. 1991. Changes in Total Body Water During Spaceflight. The
Journal of Clinical Pharmacology, 31(10), pp.1001-1006.
LeBlanc AD, Spector ER, Evans HJ, Sibonga JD. 2007. Skeletal responses to space flight and
the bed rest analog: A review. Journal of Musculoskelet and Neuronal Interaction, 7(1),
pp.33-47.
Levine RL, Cargile CB, Blaze MS, Van Rees B, Kurman RJ, Ellenson LH. 1998. PTEN
mutations and microsatellite instability in complex atypical hyperplasia, a precursor
lesion to uterine endometrioid carcinoma. Cancer Research, 58(15), pp.3254-3258.
Li J. 1997. PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain,
Breast, and Prostate Cancer. Science, 275(5308), pp.1943-1947.
Little J. 2000. Radiation carcinogenesis. Carcinogenesis, 21(3), pp.397-404.
March HC. 1994. Leukemia in radiologists. Radiology, 43(3), pp.275-278.

54

McCain J. 2013. The MAPK (ERK) Pathway: Investigational Combinations for the Treatment
Of BRAF-Mutated Metastatic Melanoma. P T, 38(2), pp.96-108.
Mehta S, Cohrs R, Forghani B, Zerbe G, Gilden D, Pierson D. 2003. Stress-induced subclinical
reactivation of varicella zoster virus in astronauts. Journal of Medical Virology, 72(1),
pp.174-179.
Mehta S, Stowe R, Feiveson A, Tyring S, Pierson D. 2000. Reactivation and Shedding of
Cytomegalovirus in Astronauts during Spaceflight. The Journal of Infectious Diseases,
182(6), pp.1761-1764.
Morey-Holton ER, Globus RK. 2002. Hindlimb unloading rodent model: technical aspects.
Journal of Applied Physiology, 92(4), pp.1367-1377.
Mullenders L, Atkinson M, Paretzke H, Sabatier L, Bouffler S. 2009. Assessing cancer risks of
low-dose radiation. Nature Reviews Cancer, 9(8), pp.596-604.
NASA Facts. National Aeronautics and Space Administration. 2002. Understanding Space
Radiation (FS-2002-10-080-JSC). Lyndon B. Johnson Space Center.
Naumann R. 2011. The role of the phosphatidylinositol 3-kinase (PI3K) pathway in the
development and treatment of uterine cancer. Gynecologic Oncology, 123(2), pp.411420.
Nichiporuk I, Evdokimov V, Erasova V, Smirnov O, Goncharova A, Vassilieva Yu G, Vorobiev
D. 1998. Male reproductive system in conditions of bed-rest in a head down tilt. Journal
of gravitational physiology, 5(1), pp.101–102.
Ogilvy-Stuart A, Shalet S. 1993. Effect of Radiation on the Human Reproductive System.
Environmental Health Perspectives, 101, pp.109.
Osaki M, Oshimura M, Ito H. 2004. PI3K-Akt pathway: Its functions and alterations in human
cancer. Apoptosis, 9(6), pp.667-676.
Pace N. 1977. Weightlessness: A Matter of Gravity. New England Journal of Medicine, 297(1),
pp.32-37.

55

Pierson D, Stowe R, Phillips T, Lugg D, Mehta S. 2005. Epstein–Barr virus shedding by
astronauts during space flight. Brain, Behavior, and Immunity, 19(3), pp.235-242.
Prise K, Schettino G, Folkard M, Held K. 2005. New insights on cell death from radiation
exposure. The Lancet Oncology, 6(7), pp.520-528.
Romer C, Forsman AD. 2015. The effects of the spaceflight environment on the vaginal mucin
layer of the mouse. Gravitational and Space Research. 3(1), pp.20-28.
Ronca A, Alberts J. 2000. Physiology of a Microgravity Environment Selected Contribution:
Effects of spaceflight during pregnancy on labor and birth at 1 G. Journal of Applied
Physiology, 89(2), pp.849-854.
Ronca AE, Rushing L, Tou J, Wade CE, Baer LA. 2005. Centrifugation effects on estrous cycle,
mating success and pregnancy outcome in rats. Journal of Gravitational Physiology,
12(1), pp.183-184.
Rowley M, Leach D, Warner G, Heller C. 1974. Effect of Graded Doses of Ionizing Radiation
on the Human Testis. Radiation Research, 59(3), pp.665.
Shaul Y, Seger R. 2007. The MEK/ERK cascade: From signaling specificity to diverse
functions. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1773(8),
pp.1213-1226.
Sherman ME, Sturgeon S, Brinton LA, Potischman N, Kurman RJ, Berman ML, Mortel R,
Twiggs LB, Barrett RJ, Wilbanks GD. 1997. Risk factors and hormone levels in patients
with serous and endometrioid uterine carcinomas. Modern Pathology, 10, pp.963–968.
Smith IM, Forsman AD. 2012. Ovarian follicular and luteal development in the spaceflight
mouse. Gravitational and Space Biology, 26(2), pp.30-37
Smith S, Heer M. 2002. Calcium and bone metabolism during space flight. Nutrition, 18(10),
pp.849-852.
Suman S, Johnson M, Fornace A, Datta K. 2012. Exposure to Ionizing Radiation Causes LongTerm Increase in Serum Estradiol and Activation of PI3K-Akt Signaling Pathway in

56

Mouse Mammary Gland. International Journal of Radiation Oncology*Biology*Physics,
84(2), pp.500-507.
Svalina G, Forsman AD. 2013. The effect of the space flight environment on mucin production
in the mouse uterine tube. Advances in Space Research, 51(12), pp.2229-2234.
Tamma R, Colaianni G, Camerino C, Di Benedetto A, Greco G, Strippoli M, Vergari R, Grano
A, Mancini L, Mori G, et al. 2009. Microgravity during spaceflight directly affects in
vitro osteoclastogenesis and bone resorption. The FASEB Journal, 23(8), pp.2549-2554.
Tash J, Johnson D, Enders G. 2002. Long-term (6-wk) hindlimb suspension inhibits
spermatogenesis in adult male rats. Journal of Applied Physiology, 92(3), pp.1191-1198.
Tashiro H, Blazes MS, Wu R, Cho KR, Bose S, Wang SI, Li J, Parsons R, Ellenson LH. 1997.
Mutations in PTEN are frequent in endometrial carcinoma but rare in other common
gynecological malignancies. Cancer Research, 57(18), pp.3935-3940.
Thompson DE, Mabuchi K, Ron E, Soda M, Tokunaga M, Ochikubo S, Sugimoto S, Ikeda T,
Terasaki M, Izumi S, et al. 1994. Cancer incidence in atomic bomb survivors, part II:
solid tumors, 1958-1987. Radiation Research, 137(2), pp. S17-S67.
Tischler M, Henriksen E, Munoz K, Stump C, Woodman C, Kirby C. 1993. Spaceflight on STS48 and earth-based unweighting produce similar effects on skeletal muscle of young rats.
Journal of Applied Physiology, 74(5), pp.2161-2165.
Tou J, Grindeland R, Wade C. 2004. Effects of diet and exposure to hindlimb suspension on
estrous cycling in Sprague-Dawley rats. American Journal of Physiology-Endocrinology
and Metabolism, 286(3), pp. E425-E433.
U.S. Cancer Statistics Working Group. 2017. United States Cancer Statistics: 1999–2014
Incidence and Mortality Web-based Report. Atlanta (GA): Department of Health and
Human Services, Centers for Disease Control and Prevention, and National Cancer
Institute.
Vernikos J. 1995. Countermeasures: extending manned spaceflight. Acta Astronaut, 35, pp.271280.
Vernikos J. 1996. Human physiology in space. Bio Essays, 18(12), pp.1029-1037.
57

Vico L, Collet P, Guignandon A, Lafage-Proust M, Thomas T, Rehailia M, Alexandre C. 2000.
Effects of long-term microgravity exposure on cancellous and cortical weight-bearing
bones of cosmonauts. The Lancet, 355(9215), pp.1607-1611.
Vico L, Novikov VE, Very JM, Alexandre C. 1991. Bone histomorphometric comparison of rat
tibial metaphysis after 7-day tail suspension vs. 7-day spaceﬂight. Aviation, Space, and
Environmental medicine, 62(1), pp.26–31.
Washington State Department of Health. 2002. Background Radiation Natural versus Man-Made
(Fact Sheet 320-063). Division of Environmental Health Office of Radiation Protection.
Whitson PA, Pietrzyk RA, Sams CF. 1999. Space flight and the risk of renal stones. Journal of
Gravitational Physiology, 6(1), pp.87-8.
Williams D, Kuipers A, Mukai C, Thirsk R. 2009. Acclimation during space flight: effects on
human physiology. CMAJ, 180(13), pp.1317-1323.
Yamaguchi H, Wang HG. 2001. The protein kinase PKB/Akt regulates cell survival and
apoptosis by inhibiting Bax conformational change. Oncogene, 20, pp. 7779-7786
Yates B, Kerman I. 1998. Post-spaceflight orthostatic intolerance: possible relationship to
microgravity-induced plasticity in the vestibular system. Brain Research Reviews, 28(12), pp.73-82.
Yeramian A, Moreno-Bueno G, Dolcet X, Catasus L, Abal M, Colas E, Reventos J, Palacios J,
Prat J, Matias-Guiu X. 2012. Endometrial carcinoma: molecular alterations involved in
tumor development and progression. Oncogene, 32(4), pp.403-413.
Zhang P, Lo A, Huang Y, Huang G, Liang G, Mott J, Karpen GH, Blakely EA, Bissell MJ,
Barcellos-Hoff MH, Snijders AM, Mao J. 2015. Identification of genetic loci that control
mammary tumor susceptibility through the host microenvironment. Scientific Reports,
5(8919).

58

VITA
AREEJ MOSA

Education:
East Tennessee State University, Johnson City, Tennessee;
Biology, MS (Concentration: Biomedical Sciences), 2018.

Al-Quds University, Jerusalem, Palestine; College of
Dentistry, Bachelor Degree in Dental Surgery (BDS),
2014.

Professional Experience:
Graduate Teaching Assistant, Biological Sciences Department,
East Tennessee State University, Johnson City, Tennessee; 2016 2018.

Dentist, Palestinian Ministry of Health, Ramallah, Palestine.
January 2015 – August 2015.

Presentations:
Presented a poster entitled “Does microgravity increase the chance
of female astronauts developing uterine cancer?” (Master’s
research project) in the Appalachian Student Research Forum
(Biomedical and Health Science group), East Tennessee State
University, Johnson City, Tennessee, 2017.

59

